Receipt	O
of	O
thyroid	B:C0020676
hormone	I:C0020676
deficiency	I:C0020676
treatment	O
and	O
risk	O
of	O
herpes	O
zoster	I:C0019360
.	O

Receipt	O
of	O
thyroid	O
hormone	I:C0020676
deficiency	I:C0020676
treatment	B:C0087111
and	O
risk	O
of	O
herpes	O
zoster	I:C0019360
.	O

Receipt	O
of	O
thyroid	O
hormone	I:C0020676
deficiency	I:C0020676
treatment	O
and	O
risk	O
of	O
herpes	B:C0019360
zoster	I:C0019360
.	O

Thyroid	B:C0040135
hormone	I:C0040135
(	O
Thyroid	O
hormone	I:C0040135
)	O
has	O
been	O
suggested	O
to	O
control	O
herpes	O
virus	I:C0019369
gene	O
expression	I:C0017262
and	O
replication	O
in	O
neurons	O
via	O
epigenetics	O
through	O
its	O
nuclear	O
receptors	I:C0206588
.	O

Thyroid	O
hormone	I:C0040135
(	O
Thyroid	B:C0040135
hormone	I:C0040135
)	O
has	O
been	O
suggested	O
to	O
control	O
herpes	O
virus	I:C0019369
gene	O
expression	I:C0017262
and	O
replication	O
in	O
neurons	O
via	O
epigenetics	O
through	O
its	O
nuclear	O
receptors	I:C0206588
.	O

Thyroid	O
hormone	I:C0040135
(	O
Thyroid	O
hormone	I:C0040135
)	O
has	O
been	O
suggested	O
to	O
control	O
herpes	B:C0019369
virus	I:C0019369
gene	O
expression	I:C0017262
and	O
replication	O
in	O
neurons	O
via	O
epigenetics	O
through	O
its	O
nuclear	O
receptors	I:C0206588
.	O

Thyroid	O
hormone	I:C0040135
(	O
Thyroid	O
hormone	I:C0040135
)	O
has	O
been	O
suggested	O
to	O
control	O
herpes	O
virus	I:C0019369
gene	B:C0017262
expression	I:C0017262
and	O
replication	O
in	O
neurons	O
via	O
epigenetics	O
through	O
its	O
nuclear	O
receptors	I:C0206588
.	O

Thyroid	O
hormone	I:C0040135
(	O
Thyroid	O
hormone	I:C0040135
)	O
has	O
been	O
suggested	O
to	O
control	O
herpes	O
virus	I:C0019369
gene	O
expression	I:C0017262
and	O
replication	B:C0598312
in	O
neurons	O
via	O
epigenetics	O
through	O
its	O
nuclear	O
receptors	I:C0206588
.	O

Thyroid	O
hormone	I:C0040135
(	O
Thyroid	O
hormone	I:C0040135
)	O
has	O
been	O
suggested	O
to	O
control	O
herpes	O
virus	I:C0019369
gene	O
expression	I:C0017262
and	O
replication	O
in	O
neurons	B:C0027882
via	O
epigenetics	O
through	O
its	O
nuclear	O
receptors	I:C0206588
.	O

Thyroid	O
hormone	I:C0040135
(	O
Thyroid	O
hormone	I:C0040135
)	O
has	O
been	O
suggested	O
to	O
control	O
herpes	O
virus	I:C0019369
gene	O
expression	I:C0017262
and	O
replication	O
in	O
neurons	O
via	O
epigenetics	B:C1516924
through	O
its	O
nuclear	O
receptors	I:C0206588
.	O

Thyroid	O
hormone	I:C0040135
(	O
Thyroid	O
hormone	I:C0040135
)	O
has	O
been	O
suggested	O
to	O
control	O
herpes	O
virus	I:C0019369
gene	O
expression	I:C0017262
and	O
replication	O
in	O
neurons	O
via	O
epigenetics	O
through	O
its	O
nuclear	B:C0206588
receptors	I:C0206588
.	O

It	O
has	O
previously	O
been	O
shown	O
that	O
patients	O
with	O
hypothyroidism	B:C0020676
are	O
predisposed	O
to	O
herpes	O
zoster	I:C0019360
(	O
herpes	O
zoster	I:C0019360
)	O
,	O
suggesting	O
that	O
the	O
TH	O
deficiency	I:C0020676
may	O
be	O
a	O
risk	O
factor	I:C0035648
for	O
varicella	O
zoster	I:C0042338
virus	I:C0042338
(	O
varicella	O
zoster	I:C0042338
virus	I:C0042338
)	O
reactivation	O
.	O

It	O
has	O
previously	O
been	O
shown	O
that	O
patients	O
with	O
hypothyroidism	O
are	O
predisposed	O
to	O
herpes	B:C0019360
zoster	I:C0019360
(	O
herpes	O
zoster	I:C0019360
)	O
,	O
suggesting	O
that	O
the	O
TH	O
deficiency	I:C0020676
may	O
be	O
a	O
risk	O
factor	I:C0035648
for	O
varicella	O
zoster	I:C0042338
virus	I:C0042338
(	O
varicella	O
zoster	I:C0042338
virus	I:C0042338
)	O
reactivation	O
.	O

It	O
has	O
previously	O
been	O
shown	O
that	O
patients	O
with	O
hypothyroidism	O
are	O
predisposed	O
to	O
herpes	O
zoster	I:C0019360
(	O
herpes	B:C0019360
zoster	I:C0019360
)	O
,	O
suggesting	O
that	O
the	O
TH	O
deficiency	I:C0020676
may	O
be	O
a	O
risk	O
factor	I:C0035648
for	O
varicella	O
zoster	I:C0042338
virus	I:C0042338
(	O
varicella	O
zoster	I:C0042338
virus	I:C0042338
)	O
reactivation	O
.	O

It	O
has	O
previously	O
been	O
shown	O
that	O
patients	O
with	O
hypothyroidism	O
are	O
predisposed	O
to	O
herpes	O
zoster	I:C0019360
(	O
herpes	O
zoster	I:C0019360
)	O
,	O
suggesting	O
that	O
the	O
TH	B:C0020676
deficiency	I:C0020676
may	O
be	O
a	O
risk	O
factor	I:C0035648
for	O
varicella	O
zoster	I:C0042338
virus	I:C0042338
(	O
varicella	O
zoster	I:C0042338
virus	I:C0042338
)	O
reactivation	O
.	O

It	O
has	O
previously	O
been	O
shown	O
that	O
patients	O
with	O
hypothyroidism	O
are	O
predisposed	O
to	O
herpes	O
zoster	I:C0019360
(	O
herpes	O
zoster	I:C0019360
)	O
,	O
suggesting	O
that	O
the	O
TH	O
deficiency	I:C0020676
may	O
be	O
a	O
risk	B:C0035648
factor	I:C0035648
for	O
varicella	O
zoster	I:C0042338
virus	I:C0042338
(	O
varicella	O
zoster	I:C0042338
virus	I:C0042338
)	O
reactivation	O
.	O

It	O
has	O
previously	O
been	O
shown	O
that	O
patients	O
with	O
hypothyroidism	O
are	O
predisposed	O
to	O
herpes	O
zoster	I:C0019360
(	O
herpes	O
zoster	I:C0019360
)	O
,	O
suggesting	O
that	O
the	O
TH	O
deficiency	I:C0020676
may	O
be	O
a	O
risk	O
factor	I:C0035648
for	O
varicella	B:C0042338
zoster	I:C0042338
virus	I:C0042338
(	O
varicella	O
zoster	I:C0042338
virus	I:C0042338
)	O
reactivation	O
.	O

It	O
has	O
previously	O
been	O
shown	O
that	O
patients	O
with	O
hypothyroidism	O
are	O
predisposed	O
to	O
herpes	O
zoster	I:C0019360
(	O
herpes	O
zoster	I:C0019360
)	O
,	O
suggesting	O
that	O
the	O
TH	O
deficiency	I:C0020676
may	O
be	O
a	O
risk	O
factor	I:C0035648
for	O
varicella	O
zoster	I:C0042338
virus	I:C0042338
(	O
varicella	B:C0042338
zoster	I:C0042338
virus	I:C0042338
)	O
reactivation	O
.	O

The	O
aim	O
of	O
this	O
study	B:C2603343
was	O
to	O
test	O
the	O
hypothesis	O
that	O
TH	O
treatment	I:C2986608
will	O
ameliorate	O
the	O
complication	O
of	O
herpes	O
zoster	I:C0019360
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
test	O
the	O
hypothesis	O
that	O
TH	B:C2986608
treatment	I:C2986608
will	O
ameliorate	O
the	O
complication	O
of	O
herpes	O
zoster	I:C0019360
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
test	O
the	O
hypothesis	O
that	O
TH	O
treatment	I:C2986608
will	O
ameliorate	O
the	O
complication	B:C0009566
of	O
herpes	O
zoster	I:C0019360
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
test	O
the	O
hypothesis	O
that	O
TH	O
treatment	I:C2986608
will	O
ameliorate	O
the	O
complication	O
of	O
herpes	B:C0019360
zoster	I:C0019360
.	O

This	O
study	B:C2603343
investigated	O
the	O
hypothesis	O
by	O
enquiring	O
into	O
a	O
comprehensive	O
medical	I:C0242356
database	I:C0242356
at	O
Kaiser	O
Permanente	I:C1708333
Southern	I:C1708333
California	I:C1708333
(	O
Kaiser	O
Permanente	I:C1708333
Southern	I:C1708333
California	I:C1708333
)	O
to	O
verify	O
whether	O
patients	O
taking	O
Thyroid	O
hormone	I:C0040135
medication	O
experience	O
a	O
reduction	O
in	O
herpes	O
zoster	I:C0019360
occurrence	O
.	O

This	O
study	O
investigated	O
the	O
hypothesis	O
by	O
enquiring	O
into	O
a	O
comprehensive	B:C0242356
medical	I:C0242356
database	I:C0242356
at	O
Kaiser	O
Permanente	I:C1708333
Southern	I:C1708333
California	I:C1708333
(	O
Kaiser	O
Permanente	I:C1708333
Southern	I:C1708333
California	I:C1708333
)	O
to	O
verify	O
whether	O
patients	O
taking	O
Thyroid	O
hormone	I:C0040135
medication	O
experience	O
a	O
reduction	O
in	O
herpes	O
zoster	I:C0019360
occurrence	O
.	O

This	O
study	O
investigated	O
the	O
hypothesis	O
by	O
enquiring	O
into	O
a	O
comprehensive	O
medical	I:C0242356
database	I:C0242356
at	O
Kaiser	B:C1708333
Permanente	I:C1708333
Southern	I:C1708333
California	I:C1708333
(	O
Kaiser	O
Permanente	I:C1708333
Southern	I:C1708333
California	I:C1708333
)	O
to	O
verify	O
whether	O
patients	O
taking	O
Thyroid	O
hormone	I:C0040135
medication	O
experience	O
a	O
reduction	O
in	O
herpes	O
zoster	I:C0019360
occurrence	O
.	O

This	O
study	O
investigated	O
the	O
hypothesis	O
by	O
enquiring	O
into	O
a	O
comprehensive	O
medical	I:C0242356
database	I:C0242356
at	O
Kaiser	O
Permanente	I:C1708333
Southern	I:C1708333
California	I:C1708333
(	O
Kaiser	B:C1708333
Permanente	I:C1708333
Southern	I:C1708333
California	I:C1708333
)	O
to	O
verify	O
whether	O
patients	O
taking	O
Thyroid	O
hormone	I:C0040135
medication	O
experience	O
a	O
reduction	O
in	O
herpes	O
zoster	I:C0019360
occurrence	O
.	O

This	O
study	O
investigated	O
the	O
hypothesis	O
by	O
enquiring	O
into	O
a	O
comprehensive	O
medical	I:C0242356
database	I:C0242356
at	O
Kaiser	O
Permanente	I:C1708333
Southern	I:C1708333
California	I:C1708333
(	O
Kaiser	O
Permanente	I:C1708333
Southern	I:C1708333
California	I:C1708333
)	O
to	O
verify	O
whether	O
patients	O
taking	O
Thyroid	B:C0040135
hormone	I:C0040135
medication	O
experience	O
a	O
reduction	O
in	O
herpes	O
zoster	I:C0019360
occurrence	O
.	O

This	O
study	O
investigated	O
the	O
hypothesis	O
by	O
enquiring	O
into	O
a	O
comprehensive	O
medical	I:C0242356
database	I:C0242356
at	O
Kaiser	O
Permanente	I:C1708333
Southern	I:C1708333
California	I:C1708333
(	O
Kaiser	O
Permanente	I:C1708333
Southern	I:C1708333
California	I:C1708333
)	O
to	O
verify	O
whether	O
patients	O
taking	O
Thyroid	O
hormone	I:C0040135
medication	B:C2081612
experience	O
a	O
reduction	O
in	O
herpes	O
zoster	I:C0019360
occurrence	O
.	O

This	O
study	O
investigated	O
the	O
hypothesis	O
by	O
enquiring	O
into	O
a	O
comprehensive	O
medical	I:C0242356
database	I:C0242356
at	O
Kaiser	O
Permanente	I:C1708333
Southern	I:C1708333
California	I:C1708333
(	O
Kaiser	O
Permanente	I:C1708333
Southern	I:C1708333
California	I:C1708333
)	O
to	O
verify	O
whether	O
patients	O
taking	O
Thyroid	O
hormone	I:C0040135
medication	O
experience	O
a	O
reduction	O
in	O
herpes	B:C0019360
zoster	I:C0019360
occurrence	O
.	O

It	O
was	O
shown	O
by	O
Kaplan	O
-	O
Meier	O
analysis	O
that	O
hypothyroidism	B:C0020676
patients	O
taking	O
Thyroid	O
hormone	I:C0040135
medicines	O
had	O
a	O
lower	O
risk	O
of	O
herpes	O
zoster	I:C0019360
.	O

It	O
was	O
shown	O
by	O
Kaplan	O
-	O
Meier	O
analysis	O
that	O
hypothyroidism	O
patients	O
taking	O
Thyroid	B:C0040135
hormone	I:C0040135
medicines	O
had	O
a	O
lower	O
risk	O
of	O
herpes	O
zoster	I:C0019360
.	O

It	O
was	O
shown	O
by	O
Kaplan	O
-	O
Meier	O
analysis	O
that	O
hypothyroidism	O
patients	O
taking	O
Thyroid	O
hormone	I:C0040135
medicines	B:C0013227
had	O
a	O
lower	O
risk	O
of	O
herpes	O
zoster	I:C0019360
.	O

It	O
was	O
shown	O
by	O
Kaplan	O
-	O
Meier	O
analysis	O
that	O
hypothyroidism	O
patients	O
taking	O
Thyroid	O
hormone	I:C0040135
medicines	O
had	O
a	O
lower	O
risk	O
of	O
herpes	B:C0019360
zoster	I:C0019360
.	O

The	O
fully	O
adjusted	O
analysis	B:C0936012
indicated	O
that	O
patients	O
receiving	O
medication	O
for	O
the	O
treatment	O
of	O
TH	O
deficiency	I:C0020676
exhibited	O
a	O
reduced	O
risk	O
of	O
herpes	O
zoster	I:C0019360
(	O
hazard	O
ratio	O
0.60	O
,	O
95	O
%	O
confidence	O
interval	O
0.51	O
-0.71	O
)	O
.	O

The	O
fully	O
adjusted	O
analysis	O
indicated	O
that	O
patients	O
receiving	O
medication	B:C2081612
for	O
the	O
treatment	O
of	O
TH	O
deficiency	I:C0020676
exhibited	O
a	O
reduced	O
risk	O
of	O
herpes	O
zoster	I:C0019360
(	O
hazard	O
ratio	O
0.60	O
,	O
95	O
%	O
confidence	O
interval	O
0.51	O
-0.71	O
)	O
.	O

The	O
fully	O
adjusted	O
analysis	O
indicated	O
that	O
patients	O
receiving	O
medication	O
for	O
the	O
treatment	B:C0087111
of	O
TH	O
deficiency	I:C0020676
exhibited	O
a	O
reduced	O
risk	O
of	O
herpes	O
zoster	I:C0019360
(	O
hazard	O
ratio	O
0.60	O
,	O
95	O
%	O
confidence	O
interval	O
0.51	O
-0.71	O
)	O
.	O

The	O
fully	O
adjusted	O
analysis	O
indicated	O
that	O
patients	O
receiving	O
medication	O
for	O
the	O
treatment	O
of	O
TH	B:C0020676
deficiency	I:C0020676
exhibited	O
a	O
reduced	O
risk	O
of	O
herpes	O
zoster	I:C0019360
(	O
hazard	O
ratio	O
0.60	O
,	O
95	O
%	O
confidence	O
interval	O
0.51	O
-0.71	O
)	O
.	O

The	O
fully	O
adjusted	O
analysis	O
indicated	O
that	O
patients	O
receiving	O
medication	O
for	O
the	O
treatment	O
of	O
TH	O
deficiency	I:C0020676
exhibited	O
a	O
reduced	O
risk	O
of	O
herpes	B:C0019360
zoster	I:C0019360
(	O
hazard	O
ratio	O
0.60	O
,	O
95	O
%	O
confidence	O
interval	O
0.51	O
-0.71	O
)	O
.	O

This	O
lower	O
risk	O
of	O
herpes	B:C0019360
zoster	I:C0019360
was	O
significant	O
in	O
all	O
age	O
groups	O
except	O
the	O
18	O
-39	O
years	O
cohort	O
.	O

This	O
lower	O
risk	O
of	O
herpes	O
zoster	I:C0019360
was	O
significant	O
in	O
all	O
age	O
groups	O
except	O
the	O
18	O
-39	O
years	O
cohort	B:C0599755
.	O

In	O
addition	O
,	O
female	O
patients	O
taking	O
TH	B:C2986608
treatment	I:C2986608
exhibited	O
a	O
lower	O
risk	O
than	O
their	O
male	O
counterparts	O
.	O

Together	O
these	O
findings	B:C0243095
support	O
the	O
hypothesis	O
that	O
a	O
constant	O
level	O
of	O
Thyroid	O
hormone	I:C0040135
will	O
provide	O
a	O
degree	O
of	O
protection	O
from	O
contracting	O
herpes	O
zoster	I:C0019360
.	O

Together	O
these	O
findings	O
support	O
the	O
hypothesis	O
that	O
a	O
constant	O
level	O
of	O
Thyroid	B:C0040135
hormone	I:C0040135
will	O
provide	O
a	O
degree	O
of	O
protection	O
from	O
contracting	O
herpes	O
zoster	I:C0019360
.	O

Together	O
these	O
findings	O
support	O
the	O
hypothesis	O
that	O
a	O
constant	O
level	O
of	O
Thyroid	O
hormone	I:C0040135
will	O
provide	O
a	O
degree	O
of	O
protection	O
from	O
contracting	O
herpes	B:C0019360
zoster	I:C0019360
.	O

More	O
studies	B:C2603343
are	O
underway	O
to	O
evaluate	O
the	I:C0262707
laboratory	I:C0262707
data	I:C0262707
for	O
an	O
analysis	O
of	O
hormonal	O
effects	O
on	O
individuals	O
.	O

More	O
studies	O
are	O
underway	O
to	O
evaluate	B:C0262707
the	I:C0262707
laboratory	I:C0262707
data	I:C0262707
for	O
an	O
analysis	O
of	O
hormonal	O
effects	O
on	O
individuals	O
.	O

More	O
studies	O
are	O
underway	O
to	O
evaluate	O
the	I:C0262707
laboratory	I:C0262707
data	I:C0262707
for	O
an	O
analysis	B:C0936012
of	O
hormonal	O
effects	O
on	O
individuals	O
.	O

More	O
studies	O
are	O
underway	O
to	O
evaluate	O
the	I:C0262707
laboratory	I:C0262707
data	I:C0262707
for	O
an	O
analysis	O
of	O
hormonal	O
effects	O
on	O
individuals	B:C0027361
.	O

